Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
03/2010
03/17/2010CN101671350A Cefpiramide sodium compound of new way
03/17/2010CN101671348A Ceftizoxime sosium compound of new way
03/17/2010CN101671344A Eriosema chinense flavonoid extract and extracting method and application thereof
03/17/2010CN101671302A Production process of enrofloxacin antibacterial drug for fowl and livestock
03/17/2010CN101670102A Method for combining poxvirus vector HIV vaccine and adenoviral vector HIV vaccine and application
03/17/2010CN101670101A Attenuated live vaccine
03/17/2010CN101670094A Compound gentamycin sulfate soluble powder and preparation method thereof
03/17/2010CN101670091A Traditional Chinese medicine composite for treating swine enzootic pneumonia and preparation method thereof
03/17/2010CN101670074A Preparation method for antivirus compound
03/17/2010CN101670061A Veterinary drug for treating respiratory tract infection of poultry and preparation method thereof
03/17/2010CN101670047A Hepatitis B treating soup
03/17/2010CN101670026A Chinese and western medicine composition for treating canine parvovirus infection and preparation method thereof
03/17/2010CN101670018A Method for preparing camellia saponin controlled-release tablets
03/17/2010CN101670015A Composite for treating shrimp bacterial disease and preparation method thereof
03/17/2010CN101670014A Compound traditional Chinese medicine mixture for treating AIDS
03/17/2010CN101670013A Production method of fenugreek foot bacteriostatic spray
03/17/2010CN101670010A Method for extracting flavonoid glycoside substance
03/17/2010CN101670001A Traditional Chinese medicine composite for treating pullorum disease and preparation method thereof
03/17/2010CN101669999A External traditional Chinese medicine preparation for treating fungal dermatopathy
03/17/2010CN101669992A Distinguishing method and measuring method of perilla leaf oil
03/17/2010CN101669988A Extraction process of clerodendranthus spicatus
03/17/2010CN101669987A Identification method of Dangfei Liganning preparation
03/17/2010CN101669985A Medicament for preventing influenza
03/17/2010CN101669982A Radix isatidis dispersible tablet and preparation technology thereof
03/17/2010CN101669979A Artemisia scoparia extractive and production method and applications thereof
03/17/2010CN101669961A Method for producing Chinese-western compound preparation for preventing and treating animal synthetic respiratory diseases
03/17/2010CN101669959A Medical composite for treating livestock and poultry intestinal canal diseases and preparation method and application thereof
03/17/2010CN101669956A Composition of cefoxitin acid
03/17/2010CN101669947A Application of bis (5-butyl-2-picolinic acid-N1,O2) copper (II) for preparing anti-tuberculosis drugs
03/17/2010CN101669945A Joint synergy of ferulic acid and matrine alkaloid and medical application thereof
03/17/2010CN101669943A Oral solid preparation of faropenem and salt derivative thereof
03/17/2010CN101669939A Application of enniatine compound for preparing anti-drug-resistant tubercle bacillus drugs
03/17/2010CN101669927A Application of anthraquinone ZSU-H85 for preparing mycobacterium smegmatis resistant drugs
03/17/2010CN101669923A Adhesive patch for protecting and treating viral cutaneous lesions
03/17/2010CN101669910A Preparation of cefobutazine sodium proliposome
03/17/2010CN100594038C Human avian influenza special target medicine and preparing method thereof
03/16/2010US7678918 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; antiviral and antitumor agents
03/16/2010US7678792 e.g. 3-(5-amino-2-methylphenyl)-7-chloro-1-methyl-1,6-naphthyridin-2(1H)-one; protein kinase inhibitor; antiinflammatory, anticarcinogenic, antiallergen, antidiabetic, antiischemic, hypotensive agent
03/16/2010US7678791 4-Deoxy-3,4-[2-spiro-[1-[2-(2-methyl-5-nitro-imidazol-1-yl)ethyl]-piperidin-4-yl]]-(1H)-imidazo-(2,5-dihydro)rifamycin; antibiotic resistance; synergistic effects of covalently linking antibacterial pharmacophores together; pharmacokinetics; aerobic, anaerobic gram-positive and gram-negative bacteria
03/16/2010US7678777 increase a person immunity by oral administering a mixture including a dextran, promoting the cell growth and colonizing in the intestine of a subject without supplying L. casei subsp. casei at all times
03/16/2010US7678552 Method for selecting therapeutic agents for cancer treatment
03/16/2010US7678378 Compounds for intracellular delivery of therapeutic moieties to nerve cells
03/16/2010US7678376 Recombinant parainfluenza virus expression systems and vaccines
03/16/2010US7678370 Methods of preventing peritonitis by administering lactic acid bacterium
03/16/2010US7678369 Administering a polymer with pendant acid functional groups or a salt with a pharmaceutically acceptable cation; free of acid anhydride groups; antidiarrhea agents
03/16/2010US7678366 for high penetration into fingernails and toenails; contains humectant for trapping water and liquid nail lacquer containing film forming agent
03/16/2010CA2467695C Isomaltooligosaccharides from leuconostoc as neutraceuticals
03/16/2010CA2432006C Pharmaceutical preparation with retarding active ingredient release, method for its production and its use
03/16/2010CA2390047C Valnemulin formulation
03/16/2010CA2372575C Bradykinin receptor antagonists
03/16/2010CA2336846C Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric g protein
03/16/2010CA2274108C 2-cyclopenten-1-one and its derivatives as inhibitors of the nf-kb factor
03/16/2010CA2200054C Use of antibodies to block the effects of gram-positive bacteria and mycobacteria
03/16/2010CA2087817C 3'-derivatized oligonucleotide analogs with non-nucleotidic groupings, their preparation and use
03/11/2010WO2010028306A2 Antibodies with mannose binding lectin effector function for inhibiting pathologic inflammatory conditions
03/11/2010WO2010028215A1 Antimicrobial fish and shrimp feed
03/11/2010WO2010028116A1 Macrocyclics pyrimidines as aurora kinase inhibitors
03/11/2010WO2010028108A2 Stable pharmaceutical composition for optimized delivery of an hiv attachment inhibitor
03/11/2010WO2010027736A2 Antimicrobial protein compositions and production therefor from marine bacteria
03/11/2010WO2010027564A2 Amido anti-viral compounds, compositions, and methods of use
03/11/2010WO2010027502A2 Method of inducing an anti-viral immune response
03/11/2010WO2010027501A2 Anti-lipid antibodies
03/11/2010WO2010027431A1 Substituted tricyclic acid derivatives as s1p1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders
03/11/2010WO2010027094A1 NKT CELL-DERIVED iPS CELLS AND NKT CELLS DERIVED THEREFROM
03/11/2010WO2010027002A1 Ring-fused morpholine derivative having pi3k-inhibiting activity
03/11/2010WO2010026966A1 Novel anti-hcv agent and use thereof
03/11/2010WO2010026965A1 Cell capable of replicating novel hcv replicon, cell capable of replicating full-length hcv rna, and use of those cells
03/11/2010WO2010026730A1 Anti-viral agent
03/11/2010WO2010026652A2 Safe tooth extraction method and method of cleaning and sterilizing oral organs using neutralization reaction between sterilized water and aqueous antioxidant solution
03/11/2010WO2010026602A2 Pharmaceutical compositions containing calcium channel blockers for treatment of tuberculosis
03/11/2010WO2010026526A1 Combination therapy for tuberculosis
03/11/2010WO2010026469A1 Pharmaceutical composition for use in treating sexually transmitted infections
03/11/2010WO2010026385A1 Outer membrane vesicle prime - protein boost vaccine
03/11/2010WO2010026239A1 Composition comprising chitosan for ocular administration of vaccine(s) to avians
03/11/2010WO2010026153A1 Nucleoside derivatives as inhibitors of viral polymerases
03/11/2010WO2010026075A1 Pyridine derivatives as inhibitors of hiv-i reverse transcriptase
03/11/2010WO2010026029A1 Use of quinazoline derivatives for the treatment of viral diseases
03/11/2010WO2010025621A1 Extracts of flavonoids-containing traditional chinese medicine, extraction method, pharmaceutical composition and application thereof
03/11/2010WO2010025542A1 Lps based vaccines
03/11/2010WO2010025541A1 Identification of a conserved inner core oligosaccharide region of moraxella catarrhalis lipopolysaccharide as a vaccine antigen
03/11/2010WO2010025482A1 Organic compounds
03/11/2010WO2010008493A3 Processes for preparing high purity aza cyclohexapeptides
03/11/2010WO2010001267A3 Delivery product for topical compositions
03/11/2010WO2009158431A3 Pyrimidine derivatives as kinase inhibitors
03/11/2010WO2009155484A3 Compositions and methods of use of orf1358 from beta-hemolytic streptococcal strains
03/11/2010WO2009155476A3 Compositions and methods of use of orf 554 from beta hemolytic streptococcal strains
03/11/2010WO2009154828A3 INHIBITORS OF RecA ACTIVITIES FOR CONTROL OF ANTIBIOTIC-RESISTANT BACTERIAL PATHOGENS
03/11/2010WO2009146542A8 6-(c2-6alkylseleno)purines and methods for treating neural measles viral infection therewith
03/11/2010WO2009143483A9 PsrP IS A PROTECTIVE ANTIGEN AGAINST PNEUMOCOCCAL INFECTION
03/11/2010WO2009143133A3 Compositions and methods to protect cells by blocking entry of pathogen proteins
03/11/2010WO2009140215A3 Method for treating drug-resistant bacterial and other infections with clioquinol, phanquinone, and related compounds
03/11/2010WO2009139886A3 Targeting an hiv-1 nef-host cell kinase complex
03/11/2010WO2009129120A3 Nucleoside derivatives for treatment of caliciviridae infections, including norovirus infections
03/11/2010WO2009128964A3 Ensemble-based virtual screening reveals novel antiviral compounds for avian influenza neuraminidase
03/11/2010WO2009056322A8 Foam stabilizer for a sterilization composition
03/11/2010US20100063154 Polymorphs of acyl sulfonamides
03/11/2010US20100063144 Compounds and uses thereof
03/11/2010US20100063132 Small interfering rna and pharmaceutical composition for treatment of hepatitis b comprising the same
03/11/2010US20100063118 Hydantoins Having RNase Modulatory Activity
03/11/2010US20100063117 Novel oxazolidinone derivative with difluorophenyl moiety, pharmaceutically acceptable salt thereof, preparation method thereof and antibiotic composition containing the same as an active ingredient
1 ... 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 ... 1798